Site-directed mutagenesis of a conserved domain in vaccinia virus thymidine kinase. Evidence for a potential role in magnesium binding
- PMID: 1551887
Site-directed mutagenesis of a conserved domain in vaccinia virus thymidine kinase. Evidence for a potential role in magnesium binding
Abstract
Alignment of prokaryotic and vertebrate type II thymidine kinases (TK) (EC 2.7.1.21), such as that encoded by vaccinia virus (VVTK), reveals three conserved regions: designated domains I, III, and VII. Domains I and III of VVTK contain residues which closely resemble segments A (ATP) and B (Mg2+), respectively, of a Mg.ATP binding descriptor proposed previously (Walker, J.E., Saraster, M., Runswick, M-J., and Gay, N.J. (1982) EMBO J. 1, 945-951). In support of this hypothesis, domain I of the VVTK enzyme has previously been identified as the ATP binding site (Black and Hruby, 1990b). With regard to Mg2+ binding, several features of the VVTK domain III suggest that it may be responsible for this activity: 1) sequence similarity to a magnesium binding motif proposed previously (Walker, J.E., Saraster, M., Runswick, M-J., and Gay, N.J. (1982) EMBO J. 1, 945-951); 2) alignment of the predicted secondary structure of type II TK enzymes with other magnesium-binding enzymes such as adenylate kinase, EF-TU, and p21 reveals a conserved aspartic acid residue preceded by several hydrophobic residues with domain III; and 3) the conserved VVTK domain III aspartic acid residue (D82) aligns with D93 residue of adenylate kinase which is has been shown by NMR to participate in Mg2+ binding (Yan, H., and Tsai, M.-D., Biochemistry, in press). To directly examine the potential contribution of the conserved domain III D82 residue of VVTK in magnesium binding, site-directed mutagenesis was performed on positions D82 and G84 to generate four mutants, N82, L82, I82, and V84. Each mutant was analyzed for enzyme activity, divalent cation requirements, tetramer formation, and ATP binding ability. The results obtained were consistent with D82 playing a direct role in Mg2+ binding and suggest that while the aspartic acid does not appear to participate directly with ATP binding it may instead act to facilitate ATP hydrolysis by binding Mg2+ which aids to correctly position ATP for nucleophilic attack.
Similar articles
-
Structure of vaccinia virus thymidine kinase in complex with dTTP: insights for drug design.BMC Struct Biol. 2006 Oct 24;6:22. doi: 10.1186/1472-6807-6-22. BMC Struct Biol. 2006. PMID: 17062140 Free PMC article.
-
A single amino acid substitution abolishes feedback inhibition of vaccinia virus thymidine kinase.J Biol Chem. 1992 May 15;267(14):9743-8. J Biol Chem. 1992. PMID: 1577811
-
Identification of the ATP-binding domain of vaccinia virus thymidine kinase.J Biol Chem. 1990 Oct 15;265(29):17584-92. J Biol Chem. 1990. PMID: 2211649
-
Characterization of three essential residues in the conserved ATP-binding region of Epstein-Barr virus thymidine kinase.Biochemistry. 2005 Mar 29;44(12):4785-93. doi: 10.1021/bi0484872. Biochemistry. 2005. PMID: 15779905
-
Integrated homology modelling and X-ray study of herpes simplex virus I thymidine kinase: a case study.J Recept Signal Transduct Res. 1997 Jan-May;17(1-3):475-94. doi: 10.3109/10799899709036622. J Recept Signal Transduct Res. 1997. PMID: 9029509 Review.
Cited by
-
Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.Antimicrob Agents Chemother. 2009 Dec;53(12):5251-8. doi: 10.1128/AAC.00417-09. Epub 2009 Sep 21. Antimicrob Agents Chemother. 2009. PMID: 19770274 Free PMC article.
-
Antiviral Activity of 4'-thioIDU and Thymidine Analogs against Orthopoxviruses.Viruses. 2010 Sep;2(9):1968-1983. doi: 10.3390/v2091968. Epub 2010 Sep 16. Viruses. 2010. PMID: 21994716 Free PMC article.
-
Toward orthopoxvirus countermeasures: a novel heteromorphic nucleoside of unusual structure.J Med Chem. 2006 Jul 13;49(14):4052-4. doi: 10.1021/jm060404n. J Med Chem. 2006. PMID: 16821766 Free PMC article.
-
Structure of vaccinia virus thymidine kinase in complex with dTTP: insights for drug design.BMC Struct Biol. 2006 Oct 24;6:22. doi: 10.1186/1472-6807-6-22. BMC Struct Biol. 2006. PMID: 17062140 Free PMC article.
-
Selective phosphorylation of antiviral drugs by vaccinia virus thymidine kinase.Antimicrob Agents Chemother. 2007 May;51(5):1795-803. doi: 10.1128/AAC.01447-06. Epub 2007 Feb 26. Antimicrob Agents Chemother. 2007. PMID: 17325220 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources